Agios Pharmaceuticals, Inc. AGIO.MX Stock
Agios Pharmaceuticals, Inc. Price Chart
Agios Pharmaceuticals, Inc. AGIO.MX Financial and Trading Overview
| Agios Pharmaceuticals, Inc. stock price | 397.93 MXN |
| Previous Close | 432.08 MXN |
| Open | 0 MXN |
| Bid | 0 MXN x N/A |
| Ask | 0 MXN x N/A |
| Day's Range | 432.08 - 432.08 MXN |
| 52 Week Range | 432.08 - 651.66 MXN |
| Volume | 0 MXN |
| Avg. Volume | 0 MXN |
| Market Cap | 25.08B MXN |
| Beta (5Y Monthly) | 0.940492 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -105.77 MXN |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
AGIO.MX Valuation Measures
| Enterprise Value | 23.36B MXN |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 1318.7404 |
| Price/Book (mrq) | 23.15293 |
| Enterprise Value/Revenue | 1228.295 |
| Enterprise Value/EBITDA | -63.022 |
Trading Information
Agios Pharmaceuticals, Inc. Stock Price History
| Beta (5Y Monthly) | 0.940492 |
| 52-Week Change | -33.69% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 651.66 MXN |
| 52 Week Low | 432.08 MXN |
| 50-Day Moving Average | 432.08 MXN |
| 200-Day Moving Average | 524.04 MXN |
AGIO.MX Share Statistics
| Avg. Volume (3 month) | 0 MXN |
| Avg. Daily Volume (10-Days) | 0 MXN |
| Shares Outstanding | 55.58M |
| Float | 51.4M |
| Short Ratio | N/A |
| % Held by Insiders | 1.35% |
| % Held by Institutions | 109.02% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -1990.40% |
| Gross Margin | 104.74% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -19.023% |
| Return on Equity (ttm) | -19.43% |
Income Statement
| Revenue (ttm) | 19.02M MXN |
| Revenue Per Share (ttm) | 0.35 MXN |
| Quarterly Revenue Growth (yoy) | 574.20% |
| Gross Profit (ttm) | 12.54M MXN |
| EBITDA | -370639008 MXN |
| Net Income Avi to Common (ttm) | -218044992 MXN |
| Diluted EPS (ttm) | -68.74 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 739.2M MXN |
| Total Cash Per Share (mrq) | 13.3 MXN |
| Total Debt (mrq) | 82.34M MXN |
| Total Debt/Equity (mrq) | 7.94 MXN |
| Current Ratio (mrq) | 17.548 |
| Book Value Per Share (mrq) | 18.662 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -306926016 MXN |
| Levered Free Cash Flow (ttm) | -190762880 MXN |
Profile of Agios Pharmaceuticals, Inc.
| Country | Mexico |
| State | MA |
| City | Cambridge |
| Address | 88 Sidney Street |
| ZIP | 02139 |
| Phone | 617 649 8600 |
| Website | https://www.agios.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 389 |
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism. The company develops PYRUKYND (mitapivat), an activator of wild-type and mutant pyruvate kinase (PK), enzymes for the treatment of hemolytic anemias; and AG-946, a PK activator for treating lower-risk myelodysplastic syndrome and hemolytic anemias. Agios Pharmaceuticals, Inc. was incorporated in 2007 and is headquartered in Cambridge, Massachusetts.
Q&A For Agios Pharmaceuticals, Inc. Stock
What is a current AGIO.MX stock price?
Agios Pharmaceuticals, Inc. AGIO.MX stock price today per share is 397.93 MXN.
How to purchase Agios Pharmaceuticals, Inc. stock?
You can buy AGIO.MX shares on the Mexico exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Agios Pharmaceuticals, Inc.?
The stock symbol or ticker of Agios Pharmaceuticals, Inc. is AGIO.MX.
Which industry does the Agios Pharmaceuticals, Inc. company belong to?
The Agios Pharmaceuticals, Inc. industry is Biotechnology.
How many shares does Agios Pharmaceuticals, Inc. have in circulation?
The max supply of Agios Pharmaceuticals, Inc. shares is 70.64M.
What is Agios Pharmaceuticals, Inc. Price to Earnings Ratio (PE Ratio)?
Agios Pharmaceuticals, Inc. PE Ratio is now.
What was Agios Pharmaceuticals, Inc. earnings per share over the trailing 12 months (TTM)?
Agios Pharmaceuticals, Inc. EPS is -105.77 MXN over the trailing 12 months.
Which sector does the Agios Pharmaceuticals, Inc. company belong to?
The Agios Pharmaceuticals, Inc. sector is Healthcare.